Themis Medicare Ltd.
| BSE: 530199 | Sector: Health care |
| NSE: THEMISMED | ISIN Code: INE083B01016 |
| BSE 00:00 | 16 Aug | 823.95 |
23.95 (2.99%) |
OPEN
814.35 |
HIGH
825.15 |
LOW
805.25 |
| NSE 00:00 | 16 Aug | 823.35 |
23.45 (2.93%) |
OPEN
805.00 |
HIGH
830.35 |
LOW
805.00 |
| OPEN | 814.35 |
| PREVIOUS CLOSE | 800.00 |
| VOLUME | 385 |
| 52-Week high | 1198.80 |
| 52-Week low | 692.00 |
| P/E | 16.32 |
| Mkt Cap.(Rs cr) | 758 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Themis Medicare Ltd. (THEMISMED) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Sun Pharma.Inds. | 914.45 | 1.05 | 0.11 | 15585.98 |
| Dr Reddy's Labs | 4296.90 | 34.65 | 0.81 | 14405.20 |
| Cipla | 1033.85 | 6.50 | 0.63 | 13091.79 |
| Lupin | 684.10 | 1.50 | 0.22 | 11771.67 |
| Aurobindo Pharma | 583.85 | -9.45 | -1.59 | 11287.14 |
| Divi's Lab. | 3734.20 | 6.00 | 0.16 | 8879.82 |
| Alkem Lab | 2946.35 | -13.55 | -0.46 | 8829.81 |
| Zydus Lifesci. | 398.50 | 11.60 | 3.00 | 7981.90 |
| Glenmark Pharma. | 389.35 | 0.35 | 0.09 | 7567.93 |
| Torrent Pharma. | 1572.90 | 33.70 | 2.19 | 6742.32 |
| Apollo Hospitals | 4350.75 | 40.90 | 0.95 | 6098.30 |
| Ipca Labs. | 925.80 | -2.20 | -0.24 | 5399.36 |
| Alembic Pharma | 658.00 | 5.45 | 0.84 | 5051.44 |
| Abbott India | 19123.95 | 362.00 | 1.93 | 4919.27 |
| Laurus Labs | 577.40 | 11.65 | 2.06 | 4707.04 |
| Gland Pharma | 2339.45 | -23.85 | -1.01 | 4400.71 |
| Granules India | 316.15 | 5.70 | 1.84 | 3238.44 |
| Glaxosmi. Pharma | 1449.35 | 7.40 | 0.51 | 3217.51 |
| Ajanta Pharma | 1277.45 | 1.15 | 0.09 | 3140.64 |
| Sanofi India | 6367.15 | -15.75 | -0.25 | 2956.60 |
Quick Links for Themis Medicare:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
